Clinical trials: Consensus Development
Cancer
Geriatric Core Dataset (G-CODE) for Clinical Research in Elderly Cancer Patients
Older adults with cancer remain underrepresented in cancer clinical trials that establish new standards of care. Geriatric assessment (GA) is defined by geriatricians as a multidimensional interdisciplinary assessment of the…
- Trial name
- G-CODE (NCT03976531)
- Where
- France
- Volunteers
- 42 people
- Sponsor
- Institut Bergonié
Cancer
Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1)
In randomised phase III cancer clinical trials, the most objectively defined and only validated time-to-event endpoint is overall survival (OS).
- Trial name
- DATECAN-1 (NCT03676010)
- Testing
- Sarcoma and GIST, Breast cancer, Pancreatic cancer
- Where
- 3 sites in France
- Volunteers
- 265 people
- Sponsor
- Institut Bergonié